NEW YORK (GenomeWeb News) – Orchid Cellmark today reported that its first-quarter revenues were down 3 percent, due to the adverse impact of foreign currency translation.

The Princeton, NJ-based DNA testing services firm brought in revenues of $14 million for the three-month period ended March 31, compared to revenues of $14.5 million for the first quarter of 2008. The company said that its revenues were up 13 percent year over year on a constant currency basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.